Top

Breast Cancer Research and Treatment

Published in:

01-11-2018 | Letter to the Editor

The association between estrogen receptor alpha gene rs746432 polymorphism and the risk of breast cancer

Authors: Bei Wang, Fenlai Yuan

Published in: Breast Cancer Research and Treatment | Issue 2/2018

Excerpt

Dear Editors, …

Wang J, Higuchi R, Modugno F, Li J, Umblas N, Lee J, Lui LY, Ziv E, Tice JA, Cummings SR, Rhees B (2007) Estrogen receptor alpha haplotypes and breast cancer risk in older Caucasian women. Breast Cancer Res Treat 106(2):273–280. https://doi.org/10.1007/s10549-007-9497-8 CrossRefPubMed

Gallicchio L, Berndt SI, McSorley MA, Newschaffer CJ, Thuita LW, Argani P, Hoffman SC, Helzlsouer KJ (2006) Polymorphisms in estrogen-metabolizing and estrogen receptor genes and the risk of developing breast cancer among a cohort of women with benign breast disease. BMC Cancer 6:173. https://doi.org/10.1186/1471-2407-6-173 CrossRefPubMedPubMedCentral

Gold B, Kalush F, Bergeron J, Scott K, Mitra N, Wilson K, Ellis N, Huang H, Chen M, Lippert R, Halldorsson BV, Woodworth B, White T, Clark AG, Parl FF, Broder S, Dean M, Offit K (2004) Estrogen receptor genotypes and haplotypes associated with breast cancer risk. Cancer Res 64(24):8891–8900. https://doi.org/10.1158/0008-5472.CAN-04-1256 CrossRefPubMed

Title: The association between estrogen receptor alpha gene rs746432 polymorphism and the risk of breast cancer
Authors: Bei Wang
Fenlai Yuan
Publication date: 01-11-2018
Publisher: Springer US
Published in: Breast Cancer Research and Treatment / Issue 2/2018
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI: https://doi.org/10.1007/s10549-018-4929-1

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 2/2018

Somatic EP300-G211S mutations are associated with overall somatic mutational patterns and breast cancer specific survival in triple-negative breast cancer

Elevated BMI might more significantly affect the outcome negatively in luminal type breast cancer patients with brain metastases

Re: Elevated BMI might more significantly affect the outcome negatively in luminal type breast cancer patients with brain metastases

Histopathologic characteristics of background parenchymal enhancement (BPE) on breast MRI

Comparison of central laboratory assessments of ER, PR, HER2, and Ki67 by IHC/FISH and the corresponding mRNAs (ESR1, PGR, ERBB2, and MKi67) by RT-qPCR on an automated, broadly deployed diagnostic platform

Pure or mixed-type classical invasive lobular carcinoma might show different imaging features

Keynote webinar | Spotlight on antibody–drug conjugates in cancer